EP

EPITOPE INC/OR/

  • CIK: 0000801555
  • EIN: 93-0779127
  • Business address: 8505 SW CREEKSIDE PL, BEAVERTON, Oregon, 97005-7108

Information

  • Mailing address
    8505 S W CREEKSIDE PLACE, BEAVERTON, Oregon, 97008
  • Phone
    5036416115
  • State location
    Oregon
  • State of incorporation
    Oregon
  • Fiscal year end
    December 31
  • SIC
    2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
  • Filings
    N/A

About EPITOPE INC/OR/

EPITOPE INC/OR/ (CIK: 0000801555) is an American company incorporated in the state of Oregon. Head office is located at 8505 SW CREEKSIDE PL, BEAVERTON, Oregon, 97005-7108. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. EPITOPE INC/OR/ is a public company and trade via Over-The-Counter (OTC).

Ownership

Updating!

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by EPITOPE INC/OR/

Filings Format Description Filed/Effective File/Film Number
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000914121-00-000953 ( Act) Size: KB		 Nov-22-2000

005-39157

775738
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0000892917-00-000078 ( Act) Size: KB		 Oct-03-2000

000-15337

734069
8-K Document

Current report filing

Acc-no: 0000892917-00-000077 ( Act) Size: KB		 Sep-29-2000

001-10492

732311
425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0000892917-00-000071 ( Act) Size: 0 KB		 Aug-31-2000

10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000892917-00-000064 ( Act) Size: KB		 Aug-08-2000

001-10492

688242
425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0000892917-00-000063 ( Act) Size: 0 KB		 Jul-31-2000

425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0000892917-00-000036 ( Act) Size: 0 KB		 May-11-2000

10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000892917-00-000035 ( Act) Size: KB		 May-10-2000

001-10492

623983
8-K Document

Current report filing

Acc-no: 0000892917-00-000034 ( Act) Size: KB		 May-10-2000

001-10492

623978
425 Document

Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Acc-no: 0000892917-00-000033 ( Act) Size: 0 KB		 May-09-2000

424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0000892917-00-000027 ( Act) Size: KB		 Apr-05-2000

033-57246

593843
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0000892917-00-000024 ( Act) Size: KB		 Mar-28-2000

333-32426

580233
S-3 Document

Registration statement for specified transactions by certain issuers

Acc-no: 0000892917-00-000018 ( Act) Size: KB		 Mar-14-2000

333-32426

569012
SC 13G Document

Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0000914121-00-000238 ( Act) Size: KB		 Mar-06-2000

005-39157

561283
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0000892917-00-000015 ( Act) Size: KB		 Feb-17-2000

033-68510

548350
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0000892917-00-000014 ( Act) Size: KB		 Feb-17-2000

033-42841

548347
10-Q Document

Quarterly report pursuant to sections 13 or 15(d)

Acc-no: 0000892917-00-000012 ( Act) Size: KB		 Feb-11-2000

001-10492

532599
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0000892917-00-000009 ( Act) Size: KB		 Feb-02-2000

033-68510

520698
424B3 Document

Prospectus filed pursuant to Rule 424(b)(3)

Acc-no: 0000892917-00-000006 ( Act) Size: KB		 Jan-26-2000

033-42841

513881
DEF 14A Document

Definitive proxy statements

Acc-no: 0000892917-00-000004 ( Act) Size: KB		 Jan-11-2000

001-10492

505127

Recent 20 filings. View all EPITOPE INC/OR/ filings

Reviews

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Frequently Asked Questions

Tags:

  • EPITOPE INC/OR/ overview
  • EPITOPE INC/OR/ job
  • EPITOPE INC/OR/ stock
  • EPITOPE INC/OR/ ownership
  • EPITOPE INC/OR/ CEO
  • EPITOPE INC/OR/ documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Asep Medical Holdings Inc.
Update: May 30, 2024
ZYMETX INC
Update: Aug 26, 2022
ZyCare, Inc.
Update: Aug 26, 2022
WORLDWIDE MEDICAL CORP/CA/
Update: Aug 25, 2022
WILLS GERARD A
Update: Aug 25, 2022
WIDDER KENNETH J
Update: Aug 25, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 4111 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4211 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 4471 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1286 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 4921 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 4358 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 4219 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 3531 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 2200 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by